Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 16, 2010

Promote Innovation LLC v. Watson Pharma, Inc. et al

Track this case

Case Number:

2:10-cv-00300

Court:

Texas Eastern

Nature of Suit:

Patent

Judge:

T. John Ward

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 02, 2011

    Watson Settles Androderm False Marking Suit

    Watson Pharmaceuticals Inc. has agreed to stop using packaging for its Androderm testosterone deficiency treatment allegedly labeled with expired patents in order to settle a false marking suit accusing the company of blocking innovation in the industry.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login